{"id":645,"date":"2017-09-26T11:53:40","date_gmt":"2017-09-26T11:53:40","guid":{"rendered":"http:\/\/neuroeconomix.com\/?p=645"},"modified":"2025-01-28T18:22:36","modified_gmt":"2025-01-28T23:22:36","slug":"como-cambiar-la-situacion-de-su-tecnologia-frente-a-los-ojos-de-los-pagadores","status":"publish","type":"post","link":"https:\/\/neuroeconomix.com\/es\/como-cambiar-la-situacion-de-su-tecnologia-frente-a-los-ojos-de-los-pagadores\/","title":{"rendered":"\u00bfC\u00f3mo cambiar la situaci\u00f3n de su tecnolog\u00eda frente a los ojos de los pagadores?"},"content":{"rendered":"

[vc_row css=\u00bb.vc_custom_1533834763111{background-color: #ffffff !important;}\u00bb][vc_column][vc_custom_heading text=\u00bb\u00bfC\u00f3mo cambiar la situaci\u00f3n de su tecnolog\u00eda frente a los ojos de los pagadores?\u00bb font_container=\u00bbtag:h2|text_align:center|color:%23990d0d\u00bb use_theme_fonts=\u00bbyes\u00bb][vc_row_inner content_placement=\u00bbmiddle\u00bb][vc_column_inner width=\u00bb1\/4″][\/vc_column_inner][vc_column_inner width=\u00bb1\/4″][vc_single_image image=\u00bb1869″ img_size=\u00bb110×110″ alignment=\u00bbcenter\u00bb style=\u00bbvc_box_shadow_circle_2″ css_animation=\u00bbbounceIn\u00bb][\/vc_column_inner][vc_column_inner width=\u00bb1\/4″][vc_column_text el_class=\u00bbreferencias\u00bb]Por:\u00a0<\/strong>Fabian Hern\u00e1ndez<\/strong>
\nQu\u00edmico Farmac\u00e9utico
\nInvestigador en Econom\u00eda de la Salud
\nNeuroeconomix[\/vc_column_text][\/vc_column_inner][vc_column_inner width=\u00bb1\/4″][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text]La situaci\u00f3n coyuntural por la que atraviesa el sistema de salud ha puesto a los pagadores en una situaci\u00f3n complicada; existen carteras atrasadas e incrementos constantes en los precios de las tecnolog\u00edas sanitarias.<\/p>\n

 <\/p>\n

Adicionalmente, para 2017 no se incluyeron, en el incremento de\u00a0<\/strong>8,20% de la UPC, los costos por tecnolog\u00edas nuevas en el plan de beneficios. Esto, vuelve fundamental la asignaci\u00f3n acertada de recursos en salud.<\/strong><\/span><\/p>\n

 <\/p>\n

Usted como due\u00f1o de una tecnolog\u00eda en salud, puede visualizar a priori<\/em> la situaci\u00f3n relativa de su producto a los ojos de los pagadores, por medio de nuestra herramienta online IPx<\/em>.<\/span><\/strong><\/p>\n

 <\/p>\n

Con ella, puede saber el impacto que tendr\u00eda su producto en el presupuesto de los pagadores, comparado con la tecnolog\u00eda de referencia, en un escenario determinado. Esto puede ayudarle a dise\u00f1ar una estrategia de acceso efectiva, teniendo en cuenta las necesidades reales del pagador<\/strong>.<\/span><\/p>\n

 <\/p>\n

Al incluir una nueva tecnolog\u00eda en el mercado sanitario, es frecuente encontrar la situaci\u00f3n donde \u00e9sta es m\u00e1s costosa que la tecnolog\u00eda actual y por tanto, la estrategia de acceso es todo un gran reto. \u00a0En estas situaciones se vuelve cr\u00edtica la construcci\u00f3n de una propuesta de valor s\u00f3lida para presentarle a los pagadores<\/strong>.<\/span><\/p>\n

 <\/p>\n

Recuerde que el valor es una medida subjetiva de la percepci\u00f3n del pagador, sobre la capacidad que tiene su tecnolog\u00eda de responder a una necesidad.<\/strong><\/span><\/p>\n

 <\/p>\n

Hay diferentes formas de construir valor.<\/strong><\/span> Usted puede hacerlo proveyendo evidencia sobre eficacia y seguridad, mediante la realizaci\u00f3n de revisiones sistem\u00e1ticas y meta-an\u00e1lisis sobre la informaci\u00f3n publicada en la literatura cient\u00edfica.<\/p>\n

 <\/p>\n

Tambi\u00e9n puede generar evidencia econ\u00f3mica mediante estudios de costo-efectividad e impacto presupuestal<\/strong><\/span><\/p>\n

 <\/p>\n

Resaltar ventajas en aspectos log\u00edsticos, de transporte o cadena de fr\u00edo\u00a0de la tecnolog\u00eda<\/strong><\/span>, o a trav\u00e9s de la creaci\u00f3n de acuerdos de venta con portafolios completos de productos<\/strong><\/span>, o acuerdos de riesgo compartido y pago por desempe\u00f1o.<\/strong><\/span><\/p>\n

 <\/p>\n

Puede acceder a la herramienta IPx<\/span> por medio de este enlace: http:\/\/neuroeconomix.com\/soluciones\/<\/a><\/strong><\/span>[\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":"

[vc_row css=\u00bb.vc_custom_1533834763111{background-color: #ffffff !important;}\u00bb][vc_column][vc_custom_heading text=\u00bb\u00bfC\u00f3mo cambiar la situaci\u00f3n de su tecnolog\u00eda frente a los ojos de los pagadores?\u00bb font_container=\u00bbtag:h2|text_align:center|color:%23990d0d\u00bb use_theme_fonts=\u00bbyes\u00bb][vc_row_inner content_placement=\u00bbmiddle\u00bb][vc_column_inner width=\u00bb1\/4″][\/vc_column_inner][vc_column_inner width=\u00bb1\/4″][vc_single_image image=\u00bb1869″ img_size=\u00bb110×110″…<\/p>\n","protected":false},"author":19,"featured_media":2193,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"_kad_blocks_custom_css":"","_kad_blocks_head_custom_js":"","_kad_blocks_body_custom_js":"","_kad_blocks_footer_custom_js":"","_kadence_starter_templates_imported_post":false,"_kad_post_transparent":"","_kad_post_title":"","_kad_post_layout":"","_kad_post_sidebar_id":"","_kad_post_content_style":"","_kad_post_vertical_padding":"","_kad_post_feature":"","_kad_post_feature_position":"","_kad_post_header":false,"_kad_post_footer":false,"_kad_post_classname":"","footnotes":""},"categories":[4,6],"tags":[49,50,29,31,14,47],"ppma_author":[740],"class_list":["post-645","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog","category-news-sgsss","tag-costo-efectividad","tag-estrategia-de-acceso-efectivo","tag-impacto-presupuestal","tag-pagadores","tag-riesgo-compartido","tag-tecnologia"],"taxonomy_info":{"category":[{"value":4,"label":"Blogs Publicados"},{"value":6,"label":"Novedades SGSSS"}],"post_tag":[{"value":49,"label":"costo-efectividad"},{"value":50,"label":"estrategia de acceso efectivo"},{"value":29,"label":"impacto presupuestal"},{"value":31,"label":"pagadores"},{"value":14,"label":"Riesgo compartido"},{"value":47,"label":"tecnolog\u00eda"}]},"featured_image_src_large":["https:\/\/neuroeconomix.com\/wp-content\/uploads\/2017\/09\/tec.jpg",300,225,false],"author_info":{"display_name":"NeuroEconomix","author_link":"https:\/\/neuroeconomix.com\/es\/author\/wpnotifs\/"},"comment_info":0,"category_info":[{"term_id":4,"name":"Blogs Publicados","slug":"blog","term_group":0,"term_taxonomy_id":4,"taxonomy":"category","description":"","parent":0,"count":251,"filter":"raw","cat_ID":4,"category_count":251,"category_description":"","cat_name":"Blogs Publicados","category_nicename":"blog","category_parent":0},{"term_id":6,"name":"Novedades SGSSS","slug":"news-sgsss","term_group":0,"term_taxonomy_id":6,"taxonomy":"category","description":"","parent":0,"count":45,"filter":"raw","cat_ID":6,"category_count":45,"category_description":"","cat_name":"Novedades SGSSS","category_nicename":"news-sgsss","category_parent":0}],"tag_info":[{"term_id":49,"name":"costo-efectividad","slug":"costo-efectividad","term_group":0,"term_taxonomy_id":49,"taxonomy":"post_tag","description":"","parent":0,"count":9,"filter":"raw"},{"term_id":50,"name":"estrategia de acceso efectivo","slug":"estrategia-de-acceso-efectivo","term_group":0,"term_taxonomy_id":50,"taxonomy":"post_tag","description":"","parent":0,"count":1,"filter":"raw"},{"term_id":29,"name":"impacto presupuestal","slug":"impacto-presupuestal","term_group":0,"term_taxonomy_id":29,"taxonomy":"post_tag","description":"","parent":0,"count":4,"filter":"raw"},{"term_id":31,"name":"pagadores","slug":"pagadores","term_group":0,"term_taxonomy_id":31,"taxonomy":"post_tag","description":"","parent":0,"count":4,"filter":"raw"},{"term_id":14,"name":"Riesgo compartido","slug":"riesgo-compartido","term_group":0,"term_taxonomy_id":14,"taxonomy":"post_tag","description":"","parent":0,"count":7,"filter":"raw"},{"term_id":47,"name":"tecnolog\u00eda","slug":"tecnologia","term_group":0,"term_taxonomy_id":47,"taxonomy":"post_tag","description":"","parent":0,"count":2,"filter":"raw"}],"authors":[{"term_id":740,"user_id":19,"is_guest":0,"slug":"wpnotifs","display_name":"NeuroEconomix","avatar_url":"https:\/\/neuroeconomix.com\/wp-content\/uploads\/2025\/01\/neuroeconomix-home-testimonials.svg","0":null,"1":"","2":"","3":"","4":"","5":"","6":"","7":"","8":""}],"_links":{"self":[{"href":"https:\/\/neuroeconomix.com\/es\/wp-json\/wp\/v2\/posts\/645","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/neuroeconomix.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/neuroeconomix.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/neuroeconomix.com\/es\/wp-json\/wp\/v2\/users\/19"}],"replies":[{"embeddable":true,"href":"https:\/\/neuroeconomix.com\/es\/wp-json\/wp\/v2\/comments?post=645"}],"version-history":[{"count":1,"href":"https:\/\/neuroeconomix.com\/es\/wp-json\/wp\/v2\/posts\/645\/revisions"}],"predecessor-version":[{"id":14447,"href":"https:\/\/neuroeconomix.com\/es\/wp-json\/wp\/v2\/posts\/645\/revisions\/14447"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/neuroeconomix.com\/es\/wp-json\/wp\/v2\/media\/2193"}],"wp:attachment":[{"href":"https:\/\/neuroeconomix.com\/es\/wp-json\/wp\/v2\/media?parent=645"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/neuroeconomix.com\/es\/wp-json\/wp\/v2\/categories?post=645"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/neuroeconomix.com\/es\/wp-json\/wp\/v2\/tags?post=645"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/neuroeconomix.com\/es\/wp-json\/wp\/v2\/ppma_author?post=645"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}